• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Sharecare Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    10/17/24 5:10:44 PM ET
    $SHCR
    Medical/Nursing Services
    Health Care
    Get the next $SHCR alert in real time by email
    false 0001816233 0001816233 2024-10-17 2024-10-17 0001816233 us-gaap:CommonStockMember 2024-10-17 2024-10-17 0001816233 shcr:WarrantsEachWarrantExercisableForOneShareOfCommonStockEachAtExercisePriceOf11.50PerShareMember 2024-10-17 2024-10-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

      

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): October 17, 2024 

    SHARECARE, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware  001-39535  85-1365053
    (State or other jurisdiction  (Commission  (IRS Employer
    of incorporation)  File Number)  Identification No.)

     

    255 East Paces Ferry Road NE, Suite 700

    Atlanta, Georgia 30305

    (Address of principal executive offices)

     

    Registrant's telephone number, including area code: (404) 671-4000

     

    N/A

    (Former name or former address, if changed since last report.)

       

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading
    Symbol(s)
    Name of each exchange
    on which registered
    Common Stock, par value $0.0001 per share SHCR The Nasdaq Stock Market LLC
    Warrants, each warrant exercisable for one share of common stock, each at an exercise price of $11.50 per share SHCRW The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    Item 5.07Submission of Matters to a Vote of Security Holders.

     

    On October 17, 2024, Sharecare, Inc. (“Sharecare” or the “Company”) held a special meeting of stockholders (the “Special Meeting”) to consider certain proposals related to the Agreement and Plan of Merger, dated as of June 21, 2024 (the “Merger Agreement”), by and among the Company, Impact Acquiror Inc., a Delaware corporation (“Parent”), and Impact Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”). Parent and Merger Sub are affiliates of Altaris, LLC, a Delaware limited liability company. The Merger Agreement provides that, among other things, and on the terms and subject to the conditions set forth therein, at the Effective Time (as defined in the Merger Agreement), Merger Sub will merge with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent.

     

    As of the close of business on September 16, 2024, the record date for the Special Meeting (the “Record Date”), there were 371,876,636 shares of common stock of the Company, par value $0.0001 per share (“Common Stock”), outstanding and entitled to vote at the Special Meeting and 5,000,000 shares of Series A convertible preferred stock of the Company, par value $0.0001 per share (“Preferred Stock”) outstanding and entitled to vote at the Special Meeting. At the Special Meeting, the holders of a total of 256,617,811 shares of Common Stock and 0 shares of Preferred Stock, voting together as a single class, were present in person, or by remote communication, or represented by proxy, representing approximately 68.09% of the voting power of all issued and outstanding shares of capital stock of the Company as of the Record Date and constituting a quorum for the transaction of business at the Special Meeting under the Company’s bylaws.

     

    At the Special Meeting, the Company’s stockholders voted on the following proposals and cast their votes as described below. For more information on each of these proposals, see the definitive proxy statement filed by the Company with the U.S. Securities and Exchange Commission on September 17, 2024.

     

    1.The Company’s stockholders adopted the Merger Agreement.

     

    Votes For   Votes Against   Abstentions
    254,889,846   1,656,207   71,758

     

    2.The Company’s stockholders approved, on a non-binding, advisory basis, the compensation that will or may become payable by the Company to the Company’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement.

     

    Votes For   Votes Against   Abstentions
    233,906,514   11,697,241   11,014,056

     

    The Company’s stockholders did not vote on the proposal to approve any adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies, to adopt the Merger Agreement at the time of the Special Meeting because there were sufficient votes to adopt the Merger Agreement and such adjournment was not necessary.

     

    Subject to the satisfaction or waiver of the remaining customary closing conditions set forth in the Merger Agreement, the Merger is expected to be consummated on or about October 22, 2024.

     

     

     

     

    Forward-Looking Statements

     

    This Current Report on Form 8-K contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: “outlook,” “target,” “reflect,” “on track,” “foresees,” “future,” “may,” “deliver,” “will,” “shall,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms, other comparable terminology (although not all forward-looking statements contain these words), or by discussions of strategy, plans, or intentions. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained in this Current Report on Form 8-K, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain.

     

    Forward-looking statements in this Current Report on Form 8-K include, but are not limited to, statements regarding the proposed transaction, including the benefits of the proposed transaction and the anticipated timing of consummation of the proposed transaction.  We cannot assure you that the forward-looking statements in this Current Report on Form 8-K will prove to be accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results. Risks and uncertainties include, but are not limited to: (i) the risk that the proposed transaction may not be completed in a timely manner, or at all; (ii) the failure to satisfy the conditions to the consummation of the proposed transaction; (iii) unanticipated difficulties or expenditures relating to the proposed transaction; (iv) the effect of the announcement or pendency of the proposed transaction on the Company’s plans, business relationships, operating results and operations; (v) potential difficulties retaining employees as a result of the announcement and pendency of the proposed transaction; (vi) the response of customers, channel partners and suppliers to the announcement of the proposed transaction; (vii) risks related to diverting management’s attention from the Company’s ongoing business operations; and (viii) legal proceedings, including those that may be instituted against the Company, its board of directors, its executive officers or others following the announcement of the proposed transaction. Descriptions of some of the other factors that could cause actual results to differ materially from these forward-looking statements are discussed in more detail in our filings with the SEC, including the Risk Factors section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and the Risk Factors section of the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2024. Furthermore, if the forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this Current Report on Form 8-K represent our views as of the date of this Current Report on Form 8-K. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this Current Report on Form 8-K.

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: October 17, 2024 SHARECARE, INC.
       
      By: /s/ Carrie Ratliff
        Name: Carrie Ratliff
        Title:   Chief Legal Officer

     

     

     

    Get the next $SHCR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SHCR

    DatePrice TargetRatingAnalyst
    4/1/2024Buy → Neutral
    BTIG Research
    7/20/2022$2.50Equal-Weight
    Morgan Stanley
    2/11/2022$4.50Neutral
    Goldman
    2/11/2022Neutral
    Goldman Sachs
    8/4/2021$11.00Buy
    Canaccord Genuity
    7/28/2021$15.00Buy
    BTIG Research
    More analyst ratings

    $SHCR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Sharecare Inc.

      SC 13D/A - Sharecare, Inc. (0001816233) (Subject)

      10/24/24 5:30:56 PM ET
      $SHCR
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Sharecare Inc.

      SC 13D/A - Sharecare, Inc. (0001816233) (Subject)

      10/23/24 2:54:25 PM ET
      $SHCR
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by Sharecare Inc.

      SC 13G - Sharecare, Inc. (0001816233) (Subject)

      10/2/24 12:13:42 PM ET
      $SHCR
      Medical/Nursing Services
      Health Care

    $SHCR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Sharecare downgraded by BTIG Research

      BTIG Research downgraded Sharecare from Buy to Neutral

      4/1/24 7:41:16 AM ET
      $SHCR
      Medical/Nursing Services
      Health Care
    • Morgan Stanley initiated coverage on Sharecare with a new price target

      Morgan Stanley initiated coverage of Sharecare with a rating of Equal-Weight and set a new price target of $2.50

      7/20/22 7:54:21 AM ET
      $SHCR
      Medical/Nursing Services
      Health Care
    • Goldman initiated coverage on Sharecare with a new price target

      Goldman initiated coverage of Sharecare with a rating of Neutral and set a new price target of $4.50

      2/11/22 7:17:08 AM ET
      $SHCR
      Medical/Nursing Services
      Health Care

    $SHCR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Torraco Nicole returned 43,124 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Sharecare, Inc. (0001816233) (Issuer)

      10/25/24 6:08:55 AM ET
      $SHCR
      Medical/Nursing Services
      Health Care
    • Director Sagansky Jeffrey returned 927,011 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Sharecare, Inc. (0001816233) (Issuer)

      10/25/24 6:08:45 AM ET
      $SHCR
      Medical/Nursing Services
      Health Care
    • Director Allred Jeffrey A returned 705,385 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Sharecare, Inc. (0001816233) (Issuer)

      10/25/24 6:08:35 AM ET
      $SHCR
      Medical/Nursing Services
      Health Care

    $SHCR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Sharecare Names Industry Veteran Elizabeth Delahoussaye as Chief Privacy Officer of Health Data Solutions

      ATLANTA , April 07, 2025 (GLOBE NEWSWIRE) -- Sharecare, the health tech company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced that seasoned healthcare compliance and privacy authority Elizabeth Delahoussaye has joined the company as chief privacy officer of Health Data Solutions. Through its Health Data Solutions business channel, Sharecare has a deep history and proven track record in release of information (ROI), offering providers trusted solutions that support revenue generation while reducing the administrative burden on practice staff and increasing patient satisfaction. "At Sharecare, we equip our provide

      4/7/25 9:00:00 AM ET
      $SHCR
      Medical/Nursing Services
      Health Care
    • Sharecare wins 17 Digital Health Awards in Fall 2024

      ATLANTA, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sharecare, the health tech company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced it has won 17 Digital Health Awards in the Health Information Resource Center's Fall 2024 competition. Now in its 26th year, the semiannual Digital Health Awards honor the best online and virtual health resources for both consumers and professionals. "At Sharecare, our mission is to empower every individual to take control of their health and well-being, no matter where they are in their journey," said Dawn Whaley, president and chief marketing officer at Sharecare. "From our flagship platf

      11/25/24 9:00:00 AM ET
      $SHCR
      Medical/Nursing Services
      Health Care
    • Sharecare expands suite of interactive media solutions to engage, educate, and activate patients and providers

      ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sharecare, the health tech company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, announced today a slate of six new interactive media solutions designed to engage, educate, and activate patients and providers to better understand health conditions and take meaningful action towards improved health and well-being. The expansion of Sharecare's robust suite of customer activation and management solutions enables life sciences brands to align their marketing campaigns and health promotion efforts with the latest consumer insights and industry trends. Leveraging cutting-edge technology, i

      10/31/24 9:00:00 AM ET
      $SHCR
      Medical/Nursing Services
      Health Care

    $SHCR
    SEC Filings

    See more
    • SEC Form 15-12G filed by Sharecare Inc.

      15-12G - Sharecare, Inc. (0001816233) (Filer)

      11/4/24 1:29:44 PM ET
      $SHCR
      Medical/Nursing Services
      Health Care
    • Amendment: Sharecare Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K/A - Sharecare, Inc. (0001816233) (Filer)

      10/31/24 4:43:58 PM ET
      $SHCR
      Medical/Nursing Services
      Health Care
    • SEC Form S-8 POS filed by Sharecare Inc.

      S-8 POS - Sharecare, Inc. (0001816233) (Filer)

      10/22/24 4:58:12 PM ET
      $SHCR
      Medical/Nursing Services
      Health Care

    $SHCR
    Leadership Updates

    Live Leadership Updates

    See more
    • Sharecare appoints Brent Layton to board of directors

      ATLANTA, Jan. 11, 2023 /PRNewswire/ -- Sharecare, Inc. (NASDAQ:SHCR) ("Sharecare"), the digital health company that helps people manage all their health in one place, has appointed healthcare industry veteran and retiring Centene Corporation executive Brent Layton to its board of directors and Audit Committee, effective today. Mr. Layton has more than 30 years of experience with increasing responsibility in the healthcare and public policy sectors, with extensive expertise in creating, scaling, and operating business in a highly regulated environment. Currently serving as seni

      1/11/23 7:30:00 AM ET
      $SHCR
      Medical/Nursing Services
      Health Care
    • Sharecare appoints Evan Smith to senior vice president of finance and investor relations

      ATLANTA, Oct. 20, 2021 /PRNewswire/ -- Sharecare (NASDAQ:SHCR), the digital health company that helps people manage all their health in one place, today announced that Evan Smith, CFA, has joined the company as senior vice president of finance and investor relations, reporting to Sharecare's president and chief financial officer, Justin Ferrero.   With over 25 years of investor relations and investing experience in the healthcare sector, Smith is responsible for strategic planning and development of Sharecare's investor relations activities as well as supporting growth initiat

      10/20/21 9:00:00 AM ET
      $SHCR
      Medical/Nursing Services
      Health Care

    $SHCR
    Financials

    Live finance-specific insights

    See more
    • Sharecare announces second quarter 2024 financial results and operational highlights

      ATLANTA, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ:SHCR), the digital health company that helps people manage all their health in one place, today announced financial results for the quarter ended June 30, 2024. "We began the second half of 2024 executing on our Enterprise channel strategy to expand into additional verticals with the successful launch of our new platform purpose-built for Medicaid to 750,000 members on July 1," said Brent Layton, CEO of Sharecare. "I am very enthusiastic about the opportunity to drive activation, engagement, and positive impact in these verticals at scale, leveraging our highly configurable digital capabilities, data, and services while continui

      8/9/24 7:00:00 AM ET
      $SHCR
      Medical/Nursing Services
      Health Care
    • Sharecare announces first quarter 2024 financial results and operational highlights

      ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ:SHCR), the digital health company that helps people manage all their health in one place, today announced financial results for the quarter ended March 31, 2024. "As we report first quarter earnings, we are thrilled that our purpose-built digital navigation platform for Medicaid is launching on July 1, 2024, to approximately 750,000 Medicaid members," said Brent Layton, CEO of Sharecare. "As we successfully expand into new markets leveraging our assets, we remain committed to providing measurable value to our customers and renewing long-term relationships while also growing revenue across our three divisions – and I want to reite

      5/9/24 4:05:00 PM ET
      $SHCR
      Medical/Nursing Services
      Health Care
    • Sharecare to report first quarter fiscal 2024 financial results on Thursday, May 9

      ATLANTA, April 24, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ:SHCR), the digital health company that helps people manage all their health in one place, today announced that it will report first quarter fiscal 2024 financial results on Thursday, May 9, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. EDT on the same day. Conference Call Details The conference call can be accessed by dialing (833) 636-1352 for U.S. participants, or (412) 902-4148 for international participants, and asking to be joined into the Sharecare call; or via live audio webcast, available online at https://investors.sharecare.com. A webcast rep

      4/24/24 7:00:00 AM ET
      $SHCR
      Medical/Nursing Services
      Health Care